Organisation profile
Organisation profile
Hacettepe University, founded in 1967 in Ankara, is one of Türkiye’s leading research universities with a broad disciplinary spectrum and a strong research infrastructure. Guided by the motto “To the leading edge... Toward being the best,” the University conducts multidisciplinary and innovative research that creates impact at both national and international levels.
Fingerprint
Dive into the research topics where Hacettepe University is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Mikroalg Tabanlı Biyoremediasyon Yaklaşımıyla Ağır Metal Kirliliğinin Giderimi: Tür ve Kombinasyon Etkilerinin Karşılaştırılması
Akan, A. P. (PI)
31/03/26 → 31/12/26
Project: Research › SRP
-
mRNA Yüklü Lipit Nanopartiküllerde Yardımcı Lipit Bileşiminin Fizikokimyasal Özellikler Üzerindeki Etkisinin İncelenmesi
Özalp, H. (CoI)
9/03/26 → …
Project: Research › SRP
-
mRNA Yüklü Lipit Nanopartiküllerde Yardımcı Lipit Bileşiminin Fizikokimyasal Özellikler Üzerindeki Etkisinin İncelenmesi
Aytemir, M. (PI)
9/03/26 → …
Project: Research › SRP
Research output
-
#Instagram_Injuries
Abdulsalam, A. J. & Özçakar, L., Jan 2026, In: American Journal of Physical Medicine and Rehabilitation. 105, 1, p. e11-e11Research output: Contribution to journal › Letter › peer-review
-
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) (vol 46 , pg4359 , 2025)
SC EAS Sci Document Grp, 7 Feb 2026, In: European Heart Journal. 47, 6, p. 697-697 1 p.Research output: Contribution to journal › Article › peer-review
-
3D printed intrauterine device development containing dual anticancer drugs for the treatment of uterine cancer
Varan, C., Aksüt, D., Şen, M. & Bilensoy, E., 1 Apr 2026, In: European Journal of Pharmaceutical Sciences. 219, p. 107456 107456.Research output: Contribution to journal › Article › peer-review
Open Access